CHRO insider transaction filings
Channel Therapeutics Corp — 20 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-04-15. Screen CHRO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CHRO between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Channel Therapeutics Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-15 | 4 | Simmons Chia-Lin — Director | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2025-04-15 | 4 | Francis Knuettel II — CEO, Pres., CFO, Treas & Secty | Grant/award (A): 53,988 (derivative) | EDGAR |
| 2024-11-15 | 4 | Malamut Richard — Director | Grant/award (A): 24,533 (derivative) | EDGAR |
| 2024-11-15 | 4 | Friedberg Ezra M — Director | Grant/award (A): 24,533 (derivative) | EDGAR |
| 2024-11-15 | 4 | Davis Todd C — Director | Grant/award (A): 49,605 (derivative) | EDGAR |
| 2024-09-16 | 4 | Malamut Richard — Director | Purchase (P): 10,400 @ $0.94 | EDGAR |
| 2024-09-16 | 4 | Francis Knuettel II — CEO, Pres., CFO, Treas & Secty | Purchase (P): 1,700 @ $0.97 · Purchase (P): 3,500 @ $0.97 | EDGAR |
| 2024-09-12 | 4 | Francis Knuettel II — CEO, Pres., CFO, Treas & Secty | Purchase (P): 6,500 @ $0.89 · Purchase (P): 5,500 @ $0.94 | EDGAR |
| 2024-07-02 | 4 | Francis Knuettel II — CEO, Pres., CFO Treas & Secty | Gift (G): 5,000 @ $0 · Gift (G): 15,000 @ $0 | EDGAR |
| 2024-06-18 | 4 | Lang Eric — Chief Medical Officer | Grant/award (A): 130,000 (derivative) | EDGAR |
| 2024-06-18 | 4 | Simmons Chia-Lin — Director | Grant/award (A): 90,000 (derivative) | EDGAR |
| 2024-06-18 | 4 | Malamut Richard — Director | Grant/award (A): 64,498 (derivative) | EDGAR |
| 2024-06-18 | 4 | Friedberg Ezra M — Director | Grant/award (A): 64,498 (derivative) | EDGAR |
| 2024-06-18 | 4 | Francis Knuettel II — CEO, Pres., CFO Treas & Secty | Grant/award (A): 27,778 (derivative) · Grant/award (A): 324,000 (derivative) | EDGAR |
| 2024-06-18 | 4/A | Francis Knuettel II — CEO, Pres., CFO Treas & Secty | Grant/award (A): 2,778 (derivative) | EDGAR |
| 2024-06-18 | 4 | Davis Todd C — Director | Grant/award (A): 128,977 (derivative) | EDGAR |
| 2024-03-12 | 4/A | Friedberg Ezra M — Director | Purchase (P): 16,667 @ $6 | EDGAR |
| 2024-02-23 | 4 | Friedberg Ezra M — Director | Option exercise (M): 13,649 @ $4.80 · Option exercise (M): 6,992 @ $4.80 · Conversion (C): 65,513.61 (derivative) · Conversion (C): 33,136 (derivative) | EDGAR |
| 2024-02-23 | 4 | Francis Knuettel II — Interim CEO, CFO Treas & Secty | Grant/award (A): 2,778 (derivative) | EDGAR |
| 2024-02-23 | 4 | Davis Todd C — Director | Option exercise (M): 29,167 @ $4.80 · Conversion (C) | EDGAR |
Recent 8-K events — Channel Therapeutics Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CHRO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →